» Articles » PMID: 32304082

Relevance of CTC Clusters in Breast Cancer Metastasis

Overview
Date 2020 Apr 19
PMID 32304082
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Metastasis is the major cause of mortality in patients with breast cancer; however, the mechanisms of tumor cell dissemination and metastasis formation are not well established yet. The study of circulating tumour cells (CTCs), the metastatic precursors of distant disease, may help in this search. CTCs can be found in the blood of cancer patients as single cells or as tumor cell aggregates, known as CTC clusters. CTC clusters have differential biological features such as an enhanced survival and metastatic potential, and they hold great promises for the evaluation of prognosis, diagnosis and therapy of the metastatic cancer. The analysis of CTC clusters offers new insights into the mechanism of metastasis and can guide towards the development of new diagnostic and therapeutic strategies to suppress cancer metastasis. This has become possible thanks to the development of improved technologies for detection of CTCs and CTC clusters. However, more efficient methods are needed in order to address important questions regarding the metastatic potential of CTC and future clinical applications. In this chapter, we explore the current knowledge on the role of CTC clusters in breast cancer metastasis, their origin, metastatic advantages and clinical importance.

Citing Articles

Lung cancer metastasis to artificial vascular graft post-surgery for abdominal aortic infection with pseudoaneurysm: a case description and literature analysis.

Luo J, Zhang H, Bu C, Zhang M, Liu Q, Wang J Quant Imaging Med Surg. 2025; 15(1):1080-1084.

PMID: 39838976 PMC: 11744115. DOI: 10.21037/qims-24-1391.


Circulating tumor cells: from new biological insights to clinical practice.

Gu X, Wei S, Lv X Signal Transduct Target Ther. 2024; 9(1):226.

PMID: 39218931 PMC: 11366768. DOI: 10.1038/s41392-024-01938-6.


Identification of circulating tumor cells captured by the FDA-cleared Parsortix PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations.

Ciccioli M, Kim K, Khazan N, Khoury J, Cooke M, Miller M J Exp Clin Cancer Res. 2024; 43(1):240.

PMID: 39169412 PMC: 11337573. DOI: 10.1186/s13046-024-03149-x.


Capture of circulating metastatic cancer cell clusters from lung cancer patients can reveal unique genomic profiles and potential anti-metastatic molecular targets: A proof-of-concept study.

Kouhmareh K, Martin E, Finlay D, Bhadada A, Hernandez-Vargas H, Downey F PLoS One. 2024; 19(7):e0306450.

PMID: 39083508 PMC: 11290651. DOI: 10.1371/journal.pone.0306450.


Circulating tumor cells clusters and their role in Breast cancer metastasis; a review of literature.

Sayed Z, Khattap M, Madkour M, Yasen N, Elbary H, Elsayed R Discov Oncol. 2024; 15(1):94.

PMID: 38557916 PMC: 10984915. DOI: 10.1007/s12672-024-00949-7.